# Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

> **NCT00025272** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 14 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** etoposide
- **DRUG:** topotecan hydrochloride
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00025272
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11-01
- **Primary completion:** 2005-01-18
- **Final completion:** 2005-01-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025272, "Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00025272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*